Bloterrorism-related inhalational anthrax: Can extrapolated adult guidelines be applied to a pediatric population?

Biosecurity and Bioterrorism

Volumn 5, Issue 1, 2007, Pages 35-42

  Place, Rick C ^a,b   Hanfling, Dan ^a,b   Howell, John M ^a,b,c   Mayer, Thom A ^d,e  

^a Department of Emergency Medicine ^*

^b INOVA FAIRFAX HOSPITAL   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANTHRAX; ARTICLE; BIOLOGICAL WARFARE; CHILD; EMERGENCY HEALTH SERVICE; EXPOSURE; HUMAN; MEDICAL AUDIT; PEDIATRICS; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; STANDARD; UNITED STATES;

ADOLESCENT; ADULT; ANTHRAX; BIOTERRORISM; CHILD; EMERGENCY SERVICE, HOSPITAL; GUIDELINES; HUMANS; INHALATION EXPOSURE; MEDICAL AUDIT; PEDIATRICS; RETROSPECTIVE STUDIES; TRIAGE; VIRGINIA;

EID: 34248638493     PISSN: 15387135     EISSN: None     Source Type: Journal    
DOI: 10.1089/bsp.2006.0011     Document Type: Article

References (28)

1. Mayer TA, Morrison A, Bersoff-Matcha S, et al. Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001? Clin Infect Dis 2003;36:1275-1283.
2. Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001;7:933-944.
3. Inglesby TV, O'Toole T, Henderson DA. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002;287:2236-2252.
4. Howell JM, Mayer TA, Hanfling D, et al. Screening for inhalational anthrax due to bioterrorism: evaluating proposed screening protocols. Clin Infect Dis 2004;39(12):1842-1847.
5. Danzig R. Catastrophic Bioterrorism - What Is To Be Done? Washington, DC: Center for Technology and National Security Policy; 2003:1.
6. Borio L, Frank D, Mani V, et al. Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA 2001;286:2554-2559.
7. Heyman D. Lessons from the Anthrax Attacks: Implications for U.S. Bioterrorism Preparedness: A Report on a National Forum on Biodefense. Washington, DC: Center for Strategic and International Studies; April 2002. Available at: http://www.fas.org/irp/threat/cbw/dtra02.pdf, Accessed on August 4, 2004.
8. Freedman A, Afonja O, Chang MW, et al. Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infant. JAMA 2002;287:869-874.
9. Patt HA, Feigin FD. Diagnosis and management of suspected cases of bioterrorism: a pediatric perspective. Pediatrics 2002:109;685-692.
10. Nopar RE. Plagues on our children: the threat of biological warfare. Clin Ped 1967:6;63-73.
11. Hupert N, Bearman GM, Mushlin AI, Callahan MA. Accuracy of screening for inhalational anthrax after a bioterrorist attack. Ann Intern Med 2003:139;337-345.
12. American Academy of Pediatrics; Committee on Environmental Health and Committee on Infectious Diseases. Chemical-biological terrorism and its impact on children: a subject review. Pediatrics 2000;105:662-670.
13. Cieslak TJ, Henretig FM. Ring-a-ring-a-roses: bioterrorism and its peculiar relevance to pediatrics. Curr Opin Pediatr 2003;15:107-111.
14. Update: Interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax. MMWR Morb Mortal Wkly Rep 2001;50:1014-1016.
15. Tahernia AC, Hashemi G. Survival in anthrax meningitis. Pediatrics 1972:50;329-333.
16. Tabatabaie P, Syadati A. Bacillus anthracis as a cause of bacterial meningitis. Pediatr Infect Dis J 1993:12;1035-1037.
17. Alizad A, Ayoub E, Makki N. Intestinal anthrax in a two-year-old child. Pediatr Infect Dis J 1995;14:394-395.
18. Kaya A, Tasyaran MA, Erol S, Ozkurt Z, Ozkan B. Anthrax in adults and children: a review of 132 cases in Turkey. Eur J Clin Microbiol Infect Dis 2002;21:258-261.
19. Lamb R. Anthrax. Br Med J 1973;1:157-159.
20. Manios S, Kavaliotis I. Anthrax in children: a long forgotten, potentially fatal infection. Scand J Infect Dis 1979;11:203-206.
21. Rosenfield RL, Bernardo LM. Pediatric implications in bioterrorism part II: postexposure diagnosis and treatment, Int J Trauma Nurs 2001;7:133-136.
22. Çiftçi E, İnce E, Ülker D. Traditions, anthrax, and children. Pediatr Derm 2002;19:36-38.
23. Brtheir M, Gaucherie J, Perrin J, Gringo B, Riot D. Fulminant meningitis due to bacillus anthracis in 11-year-old girl during Ramadan. Lancet 1996;347:828.
24. Puthucheary J, Lim D, Chan I, Chay OM, Choo P. Severe acute respiratory syndrome in Singapore. Arch Dis Child 2004;89:551-556.
25. Vessal K, Yeganehdoust J, Dutz W, Kohout E. Radiological changes in inhalation anthrax: a report of radiological and pathological correlation in two cases. Clin Radiol 1975;26:471-474.
26. Edwards MS. Anthrax. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases, Vol. 1. 4th ed. Philadelphia: Saunders; 1998.
27. National Advisory Committee on Children and Terrorism. Recommendations to the Secretary of the Department of Health and Human Services. Atlanta: Centers for Disease Control and Prevention; June 12, 2003. Available at: http://www.bt.cdc.gov/children/recommend.asp. Accessed on August 4, 2004.
28. Fine AM, Wong JB, Fraser HSF, Fleisher GR, Mandl KD. Is it influenza or anthrax? A decision analytic approach to the treatment of patients with influenza-like illnesses. Ann Emerg Med 2004;43:318-328.